secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001213900-22-009250
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 1.02, 3.03, 5.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Vaccines closes $20M IPO; appoints James Sapirstein to board
-----------------------------------------------------------------------

- Closed IPO of 2,222,222 shares at $9.00/share; net proceeds ~$17.8M after underwriting costs.
- John Rice resigned from board effective Feb 23, 2022; James Sapirstein appointed to board same day.
- All outstanding series seed preferred shares converted into 5,626,365 common shares upon closing.
- Right of first refusal and co-sale agreement and voting agreement terminated in connection with IPO.
- Amended and restated certificate of incorporation and bylaws adopted effective Feb 23, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390022009250/0001213900-22-009250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390022009250/ea156152-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-009250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer